Publication
Article
BioPharm International
BioPharm International-11-01-2002Volume15 Issue 11
Inside Washington: Major Changes Ahead for FDA
Author(s):
by Jill Wechsler A new FDA commissioner will have to oversee agency consolidation and new initiatives to counter bioterrorism.
Articles in this issue
Outsourcing Outlook: Will CROs find opportunity in a Reinvigorated European R&D Sector?
Inside Washington: Major Changes Ahead for FDA
Bioinformatics Databases ? Questions of Copyright
European Editor's Report ? An Industry Comes of Age
Guest Editorial: Back to the Beginning
Employing Near-Infrared Spectroscopic Methods of Analysis for Fermentation Monitoring and Control: Part 1, Method Development
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
